Breaking News Headlines Today | Ground News

See every side of every news story

crunchbase.com image

News from crunchbase.com

Ground News rates crunchbase.com’s media bias as Center. This rating is based on a combination of the media bias ratings of a Center rating from from All Sides.

crunchbase.com’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about crunchbase.com

Where is crunchbase.com located?crunchbase.com's Website crunchbase.com's Wikipedia

Media Bias Ratings

Average Bias Rating:

Center

Center

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top crunchbase.com News

Figure Stock Surges In Nasdaq Debut After $787 Million IPO

Figure Stock Surges In Nasdaq Debut After $787 Million IPO

80% Center coverage: 5 sources

The home equity lender and stablecoin issuer launched its first day of trading as a public company, after raising both the size of its initial public offering and its price.See the Story

Exclusive: Revalia Bio Raises $14.5M To ‘Revolutionize’ Drug Development With Human Data Trials

Startups · New Haven

Exclusive: Revalia Bio Raises $14.5M To ‘Revolutionize’ Drug Development With Human Data Trials

60% Left coverage: 5 sources

New Haven, Connecticut-based Revalia Bio, a startup that helps companies test new therapies on human organs, has raised $14.5 million in seed funding, the company told Crunchbase News exclusively.See the Story

Breaking News Topics Related to crunchbase.com